Head and Neck Tumors Clinical Trials

15 clinical trials for Head and Neck Tumors across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers — RECRUITING · PHASE1
• Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region. — RECRUITING · NA
• Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors — RECRUITING
• Multiparametric Imaging-based Intraoperative Navigation for Guidance of Surgical Resection and Postoperative Radiotherapy in Patients With Head-and-neck Tumors — RECRUITING · NA
• Long-term observation of the influence of the individual diagnostic and therapeutic treatment regimen on the outcome of head and neck tumors — RECRUITING
• Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors — RECRUITING · PHASE2
• Correlation and Predictive Research of Metal Elements in Radiation-Induced Oral Mucositis — RECRUITING
• Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer — RECRUITING
• Breathomics in the Diagnosis and Prediction of Radiotherapy-Induced Oropharyngeal Mucositis in Head and Neck Tumors — RECRUITING
• A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors and Other Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO) — COMPLETED · NA
• Analysis of HPV and Biomarkers Present in the Biological Fluids of Patients Suffering From Head and Neck Cancer as a Non-invasive Strategy for Detecting Recurrence — OTHER
• Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area — TERMINATED · PHASE1
• Study of Copper Isotope in Head and Neck Cancer — OTHER
• Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable — COMPLETED · NA

Refine this search